ACR TI-RADS Ultrasound Classification Explained: A Practical Guide for Sonographers
A practical breakdown of the ACR TI-RADS 2017 thyroid nodule classification system — how points are assigned, what each category means, and when FNA is recommended.
ACR TI-RADS is the language radiologists and sonographers use to communicate thyroid nodule risk — and using it correctly is one of the highest-value skills you can develop in thyroid scanning. The system is more nuanced than it first appears, and the difference between a TR3 and TR4 nodule can change whether a patient gets a biopsy.
This guide explains ACR TI-RADS 2017 in practical terms — how the point system works, what features matter, and when FNA is and isn't recommended.
What Is ACR TI-RADS?
TI-RADS stands for Thyroid Imaging Reporting and Data System. The ACR (American College of Radiology) version published in 2017 uses a point-based scoring system across five feature categories. Points accumulate to assign a TR level (TR1–TR5), which determines whether FNA is recommended and at what size threshold.
Note: ACR TI-RADS (2017) is distinct from the Korean TIRADS and EU-TIRADS systems. SonoBuddy follows ACR TI-RADS 2017 as the US standard.
The Five Feature Categories
TI-RADS scores each nodule across five feature categories. You select only one item from each category — the one that best describes the nodule.
Category 1: Composition
| Feature | Points |
|---|---|
| Cystic or almost completely cystic | 0 |
| Spongiform | 0 |
| Mixed cystic and solid | 1 |
| Solid or almost completely solid | 2 |
Spongiform = aggregated small cysts occupying > 50% of the nodule. This is always benign-appearing and scores 0 points regardless of other features.
Category 2: Echogenicity
| Feature | Points |
|---|---|
| Anechoic | 0 |
| Hyperechoic or isoechoic | 1 |
| Hypoechoic | 2 |
| Very hypoechoic | 3 |
Very hypoechoic = more hypoechoic than the adjacent strap muscles (not just hypoechoic relative to normal thyroid).
Category 3: Shape
| Feature | Points |
|---|---|
| Wider than tall | 0 |
| Taller than wide | 3 |
Measured on a transverse image. A taller-than-wide nodule has its longest dimension in the AP plane — associated with malignancy.
Category 4: Margin
| Feature | Points |
|---|---|
| Smooth | 0 |
| Ill-defined | 0 |
| Lobulated or irregular | 2 |
| Extrathyroidal extension | 3 |
Ill-defined margins in ACR TI-RADS score 0 (counterintuitive but correct). Only lobulated/irregular or extrathyroidal extension scores points.
Category 5: Echogenic Foci
Select all that apply (this is the only additive category):
| Feature | Points |
|---|---|
| None or large comet-tail artifacts | 0 |
| Macrocalcifications | 1 |
| Peripheral (rim) calcifications | 2 |
| Punctate echogenic foci | 3 |
Punctate echogenic foci are the sonographic correlate of microcalcifications — tiny bright dots without posterior shadowing (or with tiny comet-tail artifacts). These are the highest-risk finding in this category and are associated with papillary thyroid carcinoma.
TI-RADS Level Assignment
| Total Points | TI-RADS Level | Risk | Management |
|---|---|---|---|
| 0 | TR1 — Benign | No risk | No FNA |
| 2 | TR2 — Not suspicious | < 2% | No FNA |
| 3 | TR3 — Mildly suspicious | ~5% | FNA if ≥ 2.5 cm; follow if ≥ 1.5 cm |
| 4–6 | TR4 — Moderately suspicious | ~5–20% | FNA if ≥ 1.5 cm; follow if ≥ 1.0 cm |
| ≥ 7 | TR5 — Highly suspicious | > 20% | FNA if ≥ 1.0 cm; follow if ≥ 0.5 cm |
Follow = ultrasound surveillance (typically 1 year, then 1–2 years, then 3–5 years). Specific intervals depend on TR level and nodule size.
Worked Example
A solid, hypoechoic, wider-than-tall nodule with irregular margins and punctate echogenic foci:
| Feature | Selection | Points |
|---|---|---|
| Composition | Solid | 2 |
| Echogenicity | Hypoechoic | 2 |
| Shape | Wider than tall | 0 |
| Margin | Irregular | 2 |
| Echogenic foci | Punctate | 3 |
| Total | 9 → TR5 |
This nodule would be classified as TR5 — highly suspicious. FNA is recommended if ≥ 1.0 cm.
What TI-RADS Does NOT Apply To
ACR TI-RADS is designed for incidentally discovered thyroid nodules in adults. It should not be applied to:
- Pediatric patients (separate guidelines)
- Patients with known thyroid malignancy
- Post-thyroidectomy remnant nodules
- Nodules with clinical high-risk features (palpable firm mass, rapid growth, adenopathy)
Pure Cysts and the Comet-Tail Artifact
Purely cystic nodules and those with large comet-tail artifacts (≥ 1 mm posterior reverberation echoes) are classified as TR1 or TR2 (benign or not suspicious) regardless of other features. Comet-tail artifacts indicate colloid, not calcification — they are a reassuring finding.
Do not confuse comet-tail artifacts with:
- Punctate echogenic foci (tiny, no posterior reverberation ≥ 1 mm)
- Macrocalcifications (large, strong shadow)
Multiple Nodules
When multiple nodules are present:
- Score each nodule independently
- Report the one or two highest TR-level nodules
- You do not need to score every nodule if there are many — focus on the most suspicious
Reporting Format
When documenting TI-RADS:
- Location — right/left lobe, upper/mid/lower pole, isthmus
- Size — maximum diameter in three planes
- TI-RADS score — list each feature and points, total, TR level
- Management recommendation — FNA vs. follow-up vs. no action
Example: "Right lobe, mid pole. 1.2 cm (1.2 × 0.9 × 0.8 cm). Solid (2), hypoechoic (2), wider than tall (0), smooth margin (0), punctate echogenic foci (3) = 7 points → TR5 (highly suspicious). FNA recommended."
Quick Reference: TI-RADS Points at a Glance
| Category | Max Points |
|---|---|
| Composition | 2 |
| Echogenicity | 3 |
| Shape | 3 |
| Margin | 3 |
| Echogenic foci | 3 |
| Maximum possible | 14 |
Access TI-RADS Reference in SonoBuddy
SonoBuddy's thyroid pathology section includes a TI-RADS scoring guide with all five feature categories, point values, and management thresholds — accessible in seconds during your thyroid scan.
Open SonoBuddy → Pathologies → Thyroid Nodule.
Reference: Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14(5):587-595.
SonoBuddy is a reference tool, not a diagnostic authority. Clinical decisions must involve the ordering provider and interpreting physician.
Get SonoBuddy
All reference tools in one app — works offline, built for the scan room.